Diagnostic and Therapeutic Use of Human Recombinant Thyrotropin (rhTSH)(Thyrogen®) in Well-Differentiated Thyroid Cancer - Current Indications and Future Perspectives - A Review

By  

Current Pharmaceutical Analysis, Vol. 6, Iss. 1, 2010-02 ,pp. : 1-14

Bentham Science Publishers

Access to resources Recommend Favorite

Carcinogenesis and Therapeutic Strategies in Thyroid Cancer

By  

Current Drug Targets, Vol. 11, Iss. 6, 2010-06 ,pp. : 716-732

Bentham Science Publishers

Access to resources Recommend Favorite

Annual financial impact of well-differentiated thyroid cancer care in the United States

By Lubitz Carrie C.   Kong Chung Y.   McMahon Pamela M.   Daniels Gilbert H.   Chen Yufei   Economopoulos Konstantinos P.   Gazelle G. Scott   Weinstein Milton C.  

Cancer, Vol. 120, Iss. 9, 2014-05 ,pp. : 1345-1352

Blackwell Publishing

Access to resources Recommend Favorite

Thyroglobulin Autoantibodies as Surrogate Biomarkers in the Management of Patients with Differentiated Thyroid Carcinoma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 32, 2014-10 ,pp. : 3687-3692

Bentham Science Publishers

Access to resources Recommend Favorite

Recurrent and/or metastatic thyroid cancer: therapeutic options

By Thalassinos Nicolaos   Vlassopoulou Varvara   Tzanela Marinela   Karavitaki Niki   Tzavara Ioanna  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 939-947

Informa Healthcare

Access to resources Recommend Favorite